PREDICTING DIABETES PROGRESSION USING AN ENSEMBLE OF CNN, RNN, AND LSTM MODELS

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.37943/24jnss7017
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This article presents an integrated approach to predicting diabetes progression based on an ensemble of multiple deep neural network architectures. To enhance diagnostic accuracy and reliability, convolutional neural networks (CNN), recurrent neural networks (RNN), and long short-term memory (LSTM) models are jointly utilized within a clinical decision support framework. The optimal combination of their predictions is achieved through the Dirichlet ensemble method, which adaptively distributes weights among individual models according to their validation performance. Hyperparameter optimization using the Grid Search algorithm allows systematic selection of training parameters, network depth, activation functions, and regularization techniques, ensuring better convergence and reducing overfitting risks. The study involves a comprehensive data preprocessing pipeline, including normalization, balancing, and One-Hot Encoding of categorical features, to manage heterogeneous medical datasets and minimize the effect of missing or noisy information. Experimental evaluation demonstrates that the proposed ensemble model significantly outperforms individual CNN, RNN, and LSTM architectures in terms of accuracy, sensitivity, and stability, achieving improved generalization ability and robustness to data variability. This research emphasizes the potential of ensemble deep learning approaches to strengthen modern clinical decision support systems (CDSS). The developed framework enables more precise and interpretable diagnostic predictions, contributing to early diabetes detection and prevention strategies. Furthermore, the proposed methodology can be extended to other medical classification problems, providing a flexible and adaptive analytical tool for healthcare applications. The findings confirm that adaptive ensemble methods based on the Dirichlet distribution can serve as a foundation for reliable, transparent, and intelligent clinical decision-making in future healthcare systems.